Aug 20 (Reuters) - Greencross Ltd (GXL) : FY SALES REVENUE $878.7 MILLION, UP 7% FY UNDERLYING EBITDA $97.6 MILLION VERSUS $104.2 MILLION FINAL FULLY FRANKED DIVIDEND OF 5.5 CENTS PER SHARE PLANS TO REDUCE TOTAL CAPEX IN FY19 TO ABOUT $50 MILLION
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
